A compound with the SMILES Cc1cc(-n2c(SCC(=O)Nc3ccc(Br)cc3)nc3n[nH]c(C)c3c2=N)ccc1Cl has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 9.646\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1cc(-n2c(SCC(=O)Nc3ccc(Br)cc3)nc3n[nH]c(C)c3c2=N)ccc1Cl
Cc1cc(-n2c(SCC(=O)Nc3ccc(Br)cc3)nc3n[nH]c(C)c3c2=N)ccc1Cl
N-(4-bromophenyl)-2-[[5-(4-chloro-3-methylphenyl)-4-imino-3-methyl-2H-pyrazolo[3,4-d]pyrimidin-6-yl]sulfanyl]acetamide